These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 17852158)

  • 101. Recruitment to doping and help-seeking behavior of eight female AAS users.
    Börjesson A; Gårevik N; Dahl ML; Rane A; Ekström L
    Subst Abuse Treat Prev Policy; 2016 Mar; 11():11. PubMed ID: 26945991
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Prolonged androgenic anabolic steroid (AAS) induced QT interval shortening: a suitable screening tool?
    Sculthorpe N; Taylor L; Grace FM
    Drug Test Anal; 2016 Jan; 8(1):120-2. PubMed ID: 26059219
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The neurobiology and addiction potential of anabolic androgenic steroids and the effects of growth hormone.
    Grönbladh A; Nylander E; Hallberg M
    Brain Res Bull; 2016 Sep; 126(Pt 1):127-137. PubMed ID: 27156843
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Liver pathology associated with the use of anabolic-androgenic steroids.
    Søe KL; Søe M; Gluud C
    Liver; 1992 Apr; 12(2):73-9. PubMed ID: 1535676
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids.
    Smit DL; de Hon O; Venhuis BJ; den Heijer M; de Ronde W
    Scand J Med Sci Sports; 2020 Mar; 30(3):531-539. PubMed ID: 31663164
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Illicit anabolic-androgenic steroid use.
    Kanayama G; Hudson JI; Pope HG
    Horm Behav; 2010 Jun; 58(1):111-21. PubMed ID: 19769977
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature.
    Socas L; Zumbado M; Pérez-Luzardo O; Ramos A; Pérez C; Hernández JR; Boada LD
    Br J Sports Med; 2005 May; 39(5):e27. PubMed ID: 15849280
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Behavioural manifestations of anabolic steroid use.
    Trenton AJ; Currier GW
    CNS Drugs; 2005; 19(7):571-95. PubMed ID: 15984895
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Side effects of AAS abuse: an overview.
    Turillazzi E; Perilli G; Di Paolo M; Neri M; Riezzo I; Fineschi V
    Mini Rev Med Chem; 2011 May; 11(5):374-89. PubMed ID: 21443513
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Behavioral and physiological responses to anabolic-androgenic steroids.
    Clark AS; Henderson LP
    Neurosci Biobehav Rev; 2003 Aug; 27(5):413-36. PubMed ID: 14505684
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power atheletes, and this effect is potentiated by concomitant use of growth hormone.
    Karila TA; Karjalainen JE; Mäntysaari MJ; Viitasalo MT; Seppälä TA
    Int J Sports Med; 2003 Jul; 24(5):337-43. PubMed ID: 12868044
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Violence toward women and illicit androgenic-anabolic steroid use.
    Choi PY; Pope HG
    Ann Clin Psychiatry; 1994 Mar; 6(1):21-5. PubMed ID: 7951641
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Psychiatric and medical effects of anabolic-androgenic steroid use in women.
    Gruber AJ; Pope HG
    Psychother Psychosom; 2000; 69(1):19-26. PubMed ID: 10601831
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Retrograde and oscillatory shear rate in young anabolic androgenic steroid users.
    de Souza FR; Sales ARK; Dos Santos MR; Porello RA; Fonseca GWPD; Sayegh ALC; Filho ACB; Pereira RMR; Takayama L; Oliveira TF; Yonamine M; Negrão CE; Alves MJNN
    Scand J Med Sci Sports; 2019 Mar; 29(3):422-429. PubMed ID: 30387184
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Anabolic-androgenic steroid use and correlates in Norwegian adolescents.
    Sandvik MR; Bakken A; Loland S
    Eur J Sport Sci; 2018 Jul; 18(6):903-910. PubMed ID: 29635967
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Impact of anabolic androgenic steroids on neuropeptide systems.
    Hallberg M
    Mini Rev Med Chem; 2011 May; 11(5):399-408. PubMed ID: 21443512
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Use of Anabolic-Androgenic Steroids and Male Fertility: A Systematic Review and Meta-analysis.
    Mulawkar PM; Maheshwari PN; Gauhar V; Agrawal SG; Mohammed TO; Singh AG; Tak GR; Shah US; Shukla DP; Mamankar D
    J Hum Reprod Sci; 2023; 16(4):268-285. PubMed ID: 38322636
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Side-effects of topical androgenic and anabolic substances and steroids. A short review.
    Wollina U; Pabst F; Schönlebe J; Abdel-Naser MB; Konrad H; Gruner M; Haroske G; Klemm E; Schreiber G
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Sep; 16(3):117-22. PubMed ID: 17994172
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Analysis of Elevated Levels of Nandrolone Decanoate Induced Cytochrome- P450 Alterations in Mice.
    Chowdhury P; Mahanta R
    Drug Metab Lett; 2017; 11(2):86-92. PubMed ID: 29141576
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The effects of anabolic androgenic steroids on serum ubiquinone and dolichol levels among steroid abusers.
    Karila T; Laaksonen R; Jokelainen K; Himberg JJ; Seppälä T
    Metabolism; 1996 Jul; 45(7):844-7. PubMed ID: 8692019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.